The Microarray Core Facility, supported in part by the COBRE Center for Targeted Therapeutics, is a state-of-the-art facility that conducts gene expression profiling to monitor the levels of expression of all genes in the genome.
Using the Facility’s technology, a single experiment allows researchers to determine specific alterations in gene expression in various disease states, or progression, following exposure to drugs or chemicals. 30,000 genes are expressed at different levels in a single genome, and can be monitored in a single experiment through our technology.
The Microarray Core Facility receives partial support from SC INBRE, funded by the Institutional Development Award (IDeA) program of the National Institute of General Medical Sciences. The Facility is also a member of the Network of IDeA-funded Core Laboratories (NICL).